InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,304.80
(
0.47%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.63
(
0.25%
)
Bitcoin
61,708.97
(
0.16%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Sikmarson

Send PM Follow Ignore
Followers 2
Posts 79
Boards Moderated 0
Alias Born 06/23/2014

Sikmarson

Re: None

Friday, 03/06/2015 3:32:20 PM

Friday, March 06, 2015 3:32:20 PM

Post# of 80490
On 15 January 2015, orphan designation (EU/3/14/1421) was granted by the European Commission to ARIAD Pharma Ltd, United Kingdom, for ponatinib hydrochloride for the treatment of gastrointestinal stromal tumours.
European Medicines Agency
pdf published 06/03/2015
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up